HK1250329A1 - 使用祖细胞治疗眼部病症 - Google Patents

使用祖细胞治疗眼部病症 Download PDF

Info

Publication number
HK1250329A1
HK1250329A1 HK18108224.1A HK18108224A HK1250329A1 HK 1250329 A1 HK1250329 A1 HK 1250329A1 HK 18108224 A HK18108224 A HK 18108224A HK 1250329 A1 HK1250329 A1 HK 1250329A1
Authority
HK
Hong Kong
Prior art keywords
cells
progenitor cells
treatment
ocular conditions
neuronal
Prior art date
Application number
HK18108224.1A
Other languages
English (en)
Chinese (zh)
Inventor
Harris Ian
Sophia DEJNEKA Nadine
Original Assignee
Janssen Biotech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech, Inc. filed Critical Janssen Biotech, Inc.
Publication of HK1250329A1 publication Critical patent/HK1250329A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/062—Sensory transducers, e.g. photoreceptors; Sensory neurons, e.g. for hearing, taste, smell, pH, touch, temperature, pain
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
    • C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK18108224.1A 2014-12-05 2015-12-04 使用祖细胞治疗眼部病症 HK1250329A1 (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462088429P 2014-12-05 2014-12-05
US62/088,429 2014-12-05
US201562126370P 2015-02-27 2015-02-27
US62/126,370 2015-02-27
US201562220873P 2015-09-18 2015-09-18
US62/220,873 2015-09-18
PCT/US2015/063923 WO2016090215A2 (en) 2014-12-05 2015-12-04 Treatment of ocular conditions using progenitor cells

Publications (1)

Publication Number Publication Date
HK1250329A1 true HK1250329A1 (zh) 2018-12-14

Family

ID=56092673

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108224.1A HK1250329A1 (zh) 2014-12-05 2015-12-04 使用祖细胞治疗眼部病症

Country Status (16)

Country Link
US (1) US20160158293A1 (cg-RX-API-DMAC10.html)
EP (1) EP3258946A4 (cg-RX-API-DMAC10.html)
JP (1) JP2017537702A (cg-RX-API-DMAC10.html)
KR (1) KR20170093178A (cg-RX-API-DMAC10.html)
CN (1) CN107206028A (cg-RX-API-DMAC10.html)
AU (1) AU2015358330A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017011513A2 (cg-RX-API-DMAC10.html)
CA (1) CA2969690A1 (cg-RX-API-DMAC10.html)
HK (1) HK1250329A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007207A (cg-RX-API-DMAC10.html)
PH (1) PH12017500998A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017123184A (cg-RX-API-DMAC10.html)
SG (1) SG11201704268TA (cg-RX-API-DMAC10.html)
TW (1) TW201636032A (cg-RX-API-DMAC10.html)
WO (1) WO2016090215A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704521B (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
JP7348892B2 (ja) * 2019-12-30 2023-09-21 佛教慈濟醫療財團法人 眼疾患を予防または治療する組成物及び方法
WO2021207282A2 (en) * 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
CA2761610C (en) * 2009-05-13 2020-12-29 Medipost Co., Ltd. Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
CN103998048A (zh) * 2011-07-11 2014-08-20 车比奥及戴奥斯泰有限公司 脐带提取物的制备方法和使用方法
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
MX2017007207A (es) 2018-01-30
BR112017011513A2 (pt) 2018-07-10
RU2017123184A3 (cg-RX-API-DMAC10.html) 2019-07-17
CN107206028A (zh) 2017-09-26
US20160158293A1 (en) 2016-06-09
TW201636032A (zh) 2016-10-16
EP3258946A4 (en) 2018-08-01
PH12017500998A1 (en) 2017-12-18
SG11201704268TA (en) 2017-06-29
ZA201704521B (en) 2019-01-30
JP2017537702A (ja) 2017-12-21
KR20170093178A (ko) 2017-08-14
WO2016090215A2 (en) 2016-06-09
RU2017123184A (ru) 2019-01-10
CA2969690A1 (en) 2016-06-09
AU2015358330A1 (en) 2017-06-08
EP3258946A2 (en) 2017-12-27

Similar Documents

Publication Publication Date Title
WO2015148863A3 (en) Crispr/cas-related methods and compositions for treating sickle cell disease
WO2016172658A3 (en) Microbiome regulators and related uses thereof
EP4445870A3 (en) Ophthalmic devices, system and methods that improve peripheral vision
WO2017044857A3 (en) Methods and compositions for the treatment of glaucoma
WO2017201527A3 (en) Gene therapy methods for age-related diseases and conditions
WO2015168532A3 (en) Compositions and methods for modulating pkk expression
WO2015138510A8 (en) Crispr/cas-related methods and compositions for treating leber's congenital amaurosis 10 (lca10)
HK1246286A1 (zh) Lrrk2抑制剂及其制备和使用方法
MX2015001250A (es) Composiciones y tratamiento para enfermedades y trastornos del ojo.
WO2017066712A3 (en) Modulators of telomere disease
WO2018125800A3 (en) Metalloenzyme inhibitor compounds
PH12017501028A1 (en) Treatment of retinal degeneration using progenitor cells
MX2017009417A (es) Formas solidas de acido 2-(5-(3-fluorofenil)-3-hidroxipicolinamido )acetico, composiciones y usos de las mismas.
EP4268843A3 (en) Improved il-6 antibodies
PH12017500998A1 (en) Treatment of ocular conditions using progenitor cells
MY196448A (en) Anti-Htra1 Antibodies and Methods of use Thereof
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
WO2015143447A3 (en) Methods for treating neurological disorders
WO2017066796A3 (en) Modulators of telomere disease
WO2015120372A3 (en) Compositions and methods to inhibit ezh2 for the treatment of cardiovascular diseases
WO2019087130A3 (en) Method of inhibiting angiogenesis
HK1243937A1 (zh) 治疗疾病的方法
EP4413974A3 (en) Methods of treating ocular conditions
PH12018502704A1 (en) Treatment of retinal vascular disease using progenitor cells
WO2017161344A8 (en) Compositions and methods for treating parasitic diseases